These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 17030651)

  • 1. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations.
    Lewis DA; Moghaddam B
    Arch Neurol; 2006 Oct; 63(10):1372-6. PubMed ID: 17030651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the disease process of schizophrenia: the contribution of cortical GABA neurons.
    Lewis DA; Hashimoto T
    Int Rev Neurobiol; 2007; 78():109-31. PubMed ID: 17349859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction.
    Volk DW; Lewis DA
    Physiol Behav; 2002 Dec; 77(4-5):501-5. PubMed ID: 12526990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.
    Lewis DA; Hashimoto T; Morris HM
    Neurotox Res; 2008 Oct; 14(2-3):237-48. PubMed ID: 19073429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical inhibitory neurons and schizophrenia.
    Lewis DA; Hashimoto T; Volk DW
    Nat Rev Neurosci; 2005 Apr; 6(4):312-24. PubMed ID: 15803162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiologically based treatment interventions in schizophrenia.
    Lewis DA; Gonzalez-Burgos G
    Nat Med; 2006 Sep; 12(9):1016-22. PubMed ID: 16960576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Gradients of Glutamate and Gamma-Aminobutyric Acid Transcripts in the Cortical Visuospatial Working Memory Network in Schizophrenia.
    Hoftman GD; Dienel SJ; Bazmi HH; Zhang Y; Chen K; Lewis DA
    Biol Psychiatry; 2018 Apr; 83(8):670-679. PubMed ID: 29357982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
    Gluck MR; Thomas RG; Davis KL; Haroutunian V
    Am J Psychiatry; 2002 Jul; 159(7):1165-73. PubMed ID: 12091195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
    Kimoto S; Zaki MM; Bazmi HH; Lewis DA
    JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefrontal cortical gamma-aminobutyric acid transmission and cognitive function: drawing links to schizophrenia from preclinical research.
    Tse MT; Piantadosi PT; Floresco SB
    Biol Psychiatry; 2015 Jun; 77(11):929-39. PubMed ID: 25442792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia.
    Lewis DA; Pierri JN; Volk DW; Melchitzky DS; Woo TU
    Biol Psychiatry; 1999 Sep; 46(5):616-26. PubMed ID: 10472415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia.
    Lewis DA; Cruz D; Eggan S; Erickson S
    Ann N Y Acad Sci; 2004 Jun; 1021():64-76. PubMed ID: 15251876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies.
    Stan AD; Lewis DA
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1557-62. PubMed ID: 22283765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.
    Lewis DA; Volk DW; Hashimoto T
    Psychopharmacology (Berl); 2004 Jun; 174(1):143-50. PubMed ID: 15205885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABA neurons in the human prefrontal cortex.
    Tamminga C; Hashimoto T; Volk DW; Lewis DA
    Am J Psychiatry; 2004 Oct; 161(10):1764. PubMed ID: 15465968
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic Stress Increases Prefrontal Inhibition: A Mechanism for Stress-Induced Prefrontal Dysfunction.
    McKlveen JM; Morano RL; Fitzgerald M; Zoubovsky S; Cassella SN; Scheimann JR; Ghosal S; Mahbod P; Packard BA; Myers B; Baccei ML; Herman JP
    Biol Psychiatry; 2016 Nov; 80(10):754-764. PubMed ID: 27241140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J; Mengod G
    Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Schizophrenia and cortical GABA neurotransmission].
    Hashimoto T; Matsubara T; Lewis DA
    Seishin Shinkeigaku Zasshi; 2010; 112(5):439-52. PubMed ID: 20560363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.
    Tanaka S
    Neuroscience; 2006 Apr; 139(1):153-71. PubMed ID: 16324800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional dysregulation of γ-aminobutyric acid transporter in parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia.
    Bitanihirwe BK; Woo TU
    Psychiatry Res; 2014 Dec; 220(3):1155-9. PubMed ID: 25312391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.